Newbridge Financial Services Group Inc. acquired a new position in shares of DaVita Inc. (NYSE:DVA – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 285 shares of the company’s stock, valued at approximately $30,000.
Other large investors have also modified their holdings of the company. Principal Securities Inc. acquired a new stake in shares of DaVita in the fourth quarter worth $37,000. Hanseatic Management Services Inc. acquired a new stake in shares of DaVita in the third quarter worth $36,000. GAMMA Investing LLC acquired a new stake in shares of DaVita in the fourth quarter worth $60,000. Quest Partners LLC acquired a new stake in shares of DaVita in the fourth quarter worth $74,000. Finally, Federated Hermes Inc. boosted its position in shares of DaVita by 1,284.4% in the third quarter. Federated Hermes Inc. now owns 1,246 shares of the company’s stock worth $118,000 after buying an additional 1,156 shares during the period. 90.12% of the stock is owned by institutional investors.
Insider Buying and Selling at DaVita
In other DaVita news, Director Barbara J. Desoer sold 5,030 shares of the firm’s stock in a transaction dated Friday, May 10th. The stock was sold at an average price of $138.81, for a total transaction of $698,214.30. Following the transaction, the director now directly owns 10,954 shares in the company, valued at $1,520,524.74. The transaction was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 2.00% of the company’s stock.
DaVita Price Performance
DaVita (NYSE:DVA – Get Free Report) last announced its quarterly earnings data on Thursday, May 2nd. The company reported $2.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.95 by $0.43. DaVita had a return on equity of 68.52% and a net margin of 6.61%. The business had revenue of $3.07 billion during the quarter, compared to analyst estimates of $3.03 billion. During the same period last year, the company earned $1.58 earnings per share. DaVita’s quarterly revenue was up 6.9% compared to the same quarter last year. As a group, sell-side analysts predict that DaVita Inc. will post 9.62 earnings per share for the current fiscal year.
Analysts Set New Price Targets
DVA has been the subject of several recent analyst reports. StockNews.com cut DaVita from a “strong-buy” rating to a “buy” rating in a research report on Saturday, June 8th. Barclays raised their target price on DaVita from $133.00 to $150.00 and gave the stock an “equal weight” rating in a research report on Monday, May 6th. Finally, Truist Financial increased their price objective on DaVita from $135.00 to $150.00 and gave the stock a “hold” rating in a report on Wednesday, May 15th. Two equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $144.67.
Read Our Latest Research Report on DVA
About DaVita
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Read More
- Five stocks we like better than DaVita
- Short Selling: How to Short a Stock
- Occidental Stock: Buffett’s 9-Day Buying Spree Lifts Stake to 29%
- What is a Special Dividend?
- 3M Stock: Invest Now for Unmatched Quality and Growth Potential
- Investing in the High PE Growth Stocks
- Super Micro AI Stock: Should You Invest After a 275% Increase?
Receive News & Ratings for DaVita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.com's FREE daily email newsletter.